Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
E-Sep Technologies is a private U.S. company developing separation and demineralization technology for dairy streams rather than a therapeutic biotech pipeline. Its core offering appears to be the ESEP-100 platform, which is described as enabling separation of milk proteins and minerals and full demineralization of dairy streams to produce premium food and pharmaceutical-grade ingredients. Publicly available information indicates the company operates as E-sep Technologies LLC in Belmont, California. Despite some startup databases labeling the company as "deadpooled," California business registry data indicates the legal entity remains active. Based on available evidence, the company is best characterized as a food-processing or industrial separation technology company with possible overlap into ingredients used in nutrition or pharma manufacturing, not as a life sciences drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on E-Sep Technologies.